Actinium Pharmaceuticals, Inc. (ATNM) AI Dilution Summary

Cash was $36,473,000 at 2026-06-30 against estimated monthly burn of $1,726,333. The funding channel is the active ATM program with JonesTrading Institutional Services LLC and B. Riley Securities, Inc., authorised to $200,000,000. The most recent capital raised is ATM sales through 2024-02-02: 12,230,618 shares and $98,700,000 since the program began.